NIAID Banner Logo Image

HIV Citation List: June 21 - July 4, 2013

PubMed citations

1. Multiple Antigen Peptide Mimetics Containing Gp41 Membrane-proximal External Region Elicit Broad Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 in Guinea Pigs. Zhang, L., L. Miao, X. Gong, H. Zhang, L. Yang, Y. Shi, W. Kong, C. Jiang, and Y. Shan. Journal of Peptide Science, 2013. [Epub ahead of print]. PMID[23794478].

[PubMed]. HIV_0621-070413.


2. An Engineered HIV-1 Gp41 Trimeric Coiled Coil with Increased Stability and anti-HIV-1 Activity: Implication for Developing anti-HIV Microbicides. Tong, P., Z. Lu, X. Chen, Q. Wang, F. Yu, P. Zou, X. Yu, Y. Li, L. Lu, Y.H. Chen, and S. Jiang. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23794600].

[PubMed]. HIV_0621-070413.


3. Identification of Potent and Orally Bioavailable Nucleotide Competing Reverse Transcriptase Inhibitors: In Vitro and in Vivo Optimization of a Series of Benzofurano[3,2-D]pyrimidin-2-one Derived Inhibitors. Sturino, C.F., Y. Bousquet, C.A. James, P. Deroy, M. Duplessis, P.J. Edwards, T. Halmos, J. Minville, L. Morency, S. Morin, B. Thavonekham, M. Tremblay, J. Duan, M. Ribadeneira, M. Garneau, A. Pelletier, S. Tremblay, L. Lamorte, R. Bethell, M.G. Cordingley, D. Rajotte, and B. Simoneau. Bioorganic & Medicinal Chemistry Letters, 2013. 23(13): p. 3967-3975. PMID[23673016].

[PubMed]. HIV_0621-070413.


4. Hypersusceptibility Mechanism of Tenofovir-resistant HIV to EFdA. Michailidis, E., E.M. Ryan, A. Hachiya, K.A. Kirby, B. Marchand, M.D. Leslie, A.D. Huber, Y.T. Ong, J.C. Jackson, K. Singh, E.N. Kodama, H. Mitsuya, M.A. Parniak, and S.G. Sarafianos. Retrovirology, 2013. 10(1): p. 65. PMID[23800377].

[PubMed]. HIV_0621-070413.


5. A Carboxy-terminally Truncated Human CPSF6 Lacking Residues Encoded by Exon 6 Inhibits HIV-1 cDNA Synthesis and Promotes Capsid Disassembly. Hori, T., H. Takeuchi, H. Saito, R. Sakuma, Y. Inagaki, and S. Yamaoka. Journal of Virology, 2013. 87(13): p. 7726-7736. PMID[23658440].

[PubMed]. HIV_0621-070413.


6. Bioactive Dibenzocyclooctadiene Lignans from the Stems of Schisandra neglecta. Gao, X.M., R.R. Wang, D.Y. Niu, C.Y. Meng, L.M. Yang, Y.T. Zheng, G.Y. Yang, Q.F. Hu, H.D. Sun, and W.L. Xiao. Journal of Natural Products, 2013. 76(6): p. 1052-1057. PMID[23738539].

[PubMed]. HIV_0621-070413.


7. Activation of GCN2 Upon HIV-1 Infection and Inhibition of Translation. Cosnefroy, O., A. Jaspart, C. Calmels, V. Parissi, H. Fleury, M. Ventura, S. Reigadas, and M.L. Andreola. Cellular and Molecular Life Sciences, 2013. 70(13): p. 2411-2421. PMID[23417324].

[PubMed]. HIV_0621-070413.


8. Chemically Programmed Antibodies as HIV-1 Attachment Inhibitors. Sato, S., T. Inokuma, N. Otsubo, D.R. Burton, and C.F. Barbas, 3rd. ACS Medicinal Chemistry Letters, 2013. 4(5): p. 460-465. PMID[23750312].

[PubMed]. HIV_0621-070413.

9. Inhibition of Infection and Transmission of HIV-1 and Lack of Significant Impact on the Vaginal Commensal Lactobacilli by Carbohydrate-binding Agents. Petrova, M.I., L. Mathys, S. Lebeer, S. Noppen, E.J. Van Damme, H. Tanaka, Y. Igarashi, M. Vaneechoutte, J. Vanderleyden, and J. Balzarini. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23640125].

[PubMed]. HIV_0621-070413.


10. IFN-alpha Induces APOBEC3G, F, and A in Immature Dendritic Cells and Limits HIV-1 Spread to Cd4+ T Cells. Mohanram, V., A.E. Skold, S.M. Bachle, S.K. Pathak, and A.L. Spetz. Journal of Immunology, 2013. 190(7): p. 3346-3353. PMID[23427247].

[PubMed]. HIV_0621-070413.


11. The Seventh (and Last?) International Microbicides Conference: From Discovery to Delivery. McGregor, S., G. Tachedjian, B.G. Haire, and J.M. Kaldor. Sexual Health, 2013. 10(3): p. 240-245. PMID[23702242].

[PubMed]. HIV_0621-070413.


12. In Vitro and Ex Vivo Evaluation of Polymeric Nanoparticles for Vaginal and Rectal Delivery of the anti-HIV Drug Dapivirine. das Neves, J., F. Araujo, F. Andrade, J. Michiels, K.K. Arien, G. Vanham, M. Amiji, M.F. Bahia, and B. Sarmento. Molecular Pharmaceutics, 2013. [Epub ahead of print]. PMID[23738946].

[PubMed]. HIV_0621-070413.

ISI Web of Knowledge Citations

13. Pyridine-substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 Than Ritonavir. Sevrioukova, I.F. and T.L. Poulos. Journal of Medicinal Chemistry, 2013. 56(9): p. 3733-3741. ISI[000318892500027].

[WOS]. HIV_0621-070413.


14. Structure-Activity Relationships of the Antiviral D4T and Seven 4 '-Substituted Derivatives Using MP2 and DFT Methods. Palafox, M.A. and N. Iza. Structural Chemistry, 2013. 24(3): p. 967-980. ISI[000319019200027].

[WOS]. HIV_0621-070413.


15. Silibinin Inhibits HIV-1 Infection by Reducing Cellular Activation and Proliferation. McClure, J., E.S. Lovelace, S. Elahi, N.J. Maurice, J. Wagoner, J. Dragavon, J.E. Mittler, Z. Kraft, L. Stamatatos, H. Horton, S.C. De Rosa, R.W. Coombs, and S.J. Polyak. PloS One, 2012. 7(7): p. e41832. ISI[000306806600130].

[WOS]. HIV_0621-070413.


16. N'-4-(Substituted imino)methylbenzylidene-substituted benzohydrazides: Synthesis, Antimicrobial, Antiviral, and Anticancer Evaluation, and QSAR Studies. Kumar, P., B. Narasimhan, K. Ramasamy, V. Mani, R.K. Mishra, A.A. Majeed, and E. De Clercq. Monatshefte fur Chemie, 2013. 144(6): p. 825-849. ISI[000318870600010].

[WOS]. HIV_0621-070413.


17. Alpha-helix Mimicry with Alpha/Beta-peptides. Johnson, L.M. and S.H. Gellman. Methods in Protein Design, 2013. 523: p. 407-429. ISI[000318253400020].

[WOS]. HIV_0621-070413.


18. Mechanisms of Pharmacokinetic Enhancement between Ritonavir and Saquinavir; Micro/Small Dosing Tests Using Midazolam (CYP3A4), Fexofenadine (P-glycoprotein), and Pravastatin (OATP1B1) as Probe Drugs. Ieiri, I., S. Tsunemitsu, K. Maeda, Y. Ando, N. Izumi, M. Kimura, N. Yamane, T. Okuzono, M. Morishita, N. Kotani, E. Kanda, M. Deguchi, K. Matsuguma, S. Matsuki, T. Hirota, S. Irie, H. Kusuhara, and Y. Sugiyama. Journal of Clinical Pharmacology, 2013. 53(6): p. 654-661. ISI[000319067200009].

[WOS]. HIV_0621-070413.


19. Indolizine Derivatives as HIV-1 Vifelonginc Interaction Inhibitors. Huang, W.L., T. Zuo, X. Luo, H.W. Jin, Z.M. Liu, Z.J. Yang, X.H. Yu, L.R. Zhang, and L.H. Zhang. Chemical Biology & Drug Design, 2013. 81(6): p. 730-741. ISI[000319417100006].

[WOS]. HIV_0621-070413.


20. Reducing Infectivity of HIV Upon Exposure to Surfaces Coated with N,N-dodecyl, Methyl-polyethylenimine. Gerrard, S.E., A.M. Larson, A.M. Klibanov, N.K.H. Slater, C.V. Hanson, B.F. Abrams, and M.K. Morris. Biotechnology and Bioengineering, 2013. 110(7): p. 2058-2062. ISI[000319525200026].

[WOS]. HIV_0621-070413.


21. Molecular Docking Studies of Novel Thiazolidinedione Analogs as HIV-1-RT Inhibitors. Ganguly, S. and R.S. Bahare. Medicinal Chemistry Research, 2013. 22(7): p. 3350-3363. ISI[000319359800030].

[WOS]. HIV_0621-070413.


22. Telaprevir and Boceprevir: A Potential Role for Therapeutic Drug Monitoring. Dolton, M.J., J.E. Ray, and A.J. McLachlan. Therapeutic Drug Monitoring, 2013. 35(3): p. 414-415. ISI[000319066700022].

[WOS]. HIV_0621-070413.


23. Gardiquimod: A Toll-like Receptor-7 Agonist That Inhibits HIV Type 1 Infection of Human Macrophages and Activated T Cells. Buitendijk, M., S.K. Eszterhas, and A.L. Howell. AIDS Research and Human Retroviruses, 2013. 29(6): p. 907-918. ISI[000318983000009].

[WOS]. HIV_0621-070413.


24. Synthesis and anti-HIV Activity of New Fused Chromene Derivatives Derived from 2-Amino-4-(1-naphthyl)-5-oxo-4h,5h-pyrano 3,2-C Chromene-3-carbonitrile. Al-Masoudi, N.A., H.H. Mohammed, A.M. Hamdy, O.A. Akrawi, N. Eleya, A. Spannenberg, C. Pannecouque, and P. Langer. Zeitschrift fur Naturforschung Section B-A Journal of Chemical Sciences, 2013. 68(3): p. 229-238. ISI[000318836000004].

[WOS]. HIV_0621-070413.

ISI Web of Knowledge Citations

25. Preparation of Small Molecule-polypeptide Conjugate for Inhibition of HIV Infection. Liu, K., C. Wang, W. Shi, L. Cai, K. Wang, B. Zheng, Q. Jia, S. Feng, and Y. Bai. Patent. 2013. 2012-CN84859 2013075606: 64pp.

[Patent]. HIV_0621-070413.


26. Heteroarylpyrazole-3-carboxamides as Antiviral Agents and Their Preparation and Use in the Treatment of Retroviral Infection. Wildum, S., B. Klenke, and A. Wendt. Patent. 2013. 2012-EP73944 2013079586: 222pp.

[Patent]. HIV_0621-070413.


27. Preparation of Indole Derivatives as HIV-1 Reverse Transcriptase Inhibitors. Wu, S., H. Zhou, B. Tian, C. Dong, W. Ouyang, and X. Han. Patent. 2013. 2013-10076738 103113285: 12pp.

[Patent]. HIV_0621-070413.


28. Preparation of Indolizine Derivatives as Antiviral Agents. Zhang, L., X. Yu, W. Huang, T. Zuo, Z. Yang, and L. Zhang. Patent. 2013. 2013-10014922 103087061: 41pp.

[Patent]. HIV_0621-070413.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2023